Literature DB >> 27012585

The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.

Fumihiro Shoji1, Koji Yamazaki2, Hidenori Kouso2, Ryo Mori2, Sadanori Takeo2.   

Abstract

BACKGROUND: Pleural lavage cytology (PLC) involves cytologic examination during surgery for non-small cell lung cancer (NSCLC). The timing regarding the performance of PLC is potentially important; however, a consensus remains to be established. We sought to retrospectively analyze the impact of PLC both before (pre-PLC) and after (post-PLC) lung resection on recurrence in NSCLC.
METHODS: From July 1994 to December 2011, 700 consecutive patients with surgically resected NSCLC were selected. Both pre-PLC and post-PLC status was tested using univariate and multivariate Cox regression analyses of recurrence-free survival (RFS).
RESULTS: By analyzing RFS, post-PLC status but not pre-PLC status together with pathologic N factor and pathologic stage, was identified as an independent factor for poor prognosis (p = 0.0040). A statistically significant association was observed between positive post-PLC status and pleural invasion, pathologic T factor, pathologic N factor, pathologic stage, and postoperative recurrence (p = 0.0004, p = 0.0033, p = 0.0001, p < 0.0001, and p < 0.0001, respectively). The RFS was similarly worse for patients with positive post-PLC status regardless of pre-PLC status. Conversely, the RFS was similarly better for patients with negative post-PLC status regardless of pre-PLC status.
CONCLUSIONS: Positive post-PLC status was found to be a predictive factor for postoperative recurrence in patients with surgically resected NSCLC. Moreover, post-PLC status might be an additional factor not only for identifying a patient group with a high risk of postoperative recurrence, but also to avoid unnecessary treatment of patients with low risk of postoperative recurrence.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27012585     DOI: 10.1016/j.athoracsur.2015.12.037

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Why non-grasping-lymphadenectomy technique is necessary for lung cancer resection?

Authors:  Masayuki Chida
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Clinicopathological features of intraoperative pleural lavage cytology for non-small cell lung cancer.

Authors:  Ken Onodera; Akira Sakurada; Fumihiko Hoshi; Jiro Abe; Tohru Hasumi; Satomi Takahashi; Yasuki Saito; Yoshinori Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-07-09

3.  The Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment.

Authors:  Keijiro Sugimura; Hiroshi Miyata; Masaaki Motoori; Takeshi Omori; Yoshiyuki Fujiwara; Masahiko Yano
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

4.  EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.

Authors:  Chi-Chen Fan; Wei-Chung Cheng; Yu-Chuen Huang; Yuh-Pyng Sher; Nia-Jhen Liou; Yu-Chuan Chien; Pei-Shan Lin; Pei-Syuan Lin; Chung-Hsuan Chen; Wei-Chao Chang
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

5.  Comparison of the clinical benefits for non-small cell lung cancer patients between different volume of pleural lavage fluid following video-assisted thoracoscopic lobectomy and systematic mediastinal lymph node dissection: study protocol for a randomized controlled trial.

Authors:  Jian Zhou; Chengwu Liu; Shulei Man; Mengyuan Lyu; Hu Liao; Nan Chen; Yuhui Cheng; Lunxu Liu
Journal:  Trials       Date:  2020-02-27       Impact factor: 2.279

Review 6.  [Latest Progress of Intraoperative Pleural Lavage Cytology in Lung Cancer Surgery].

Authors:  Donglai Chen; Ranran Fu; Pingfan Shi; Shuang Qin; Chang Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.